ACM
BMY icon

Ategra Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ategra Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,342
Closed -$669K – 35
2024
Q1 		$669K Sell
12,342
-4,500
-27% -$229K 0.3% 51
2023
Q4 		$864K Sell
16,842
-3,363
-17% -$177K 0.38% 46
2023
Q3 		$1.17M Sell
20,205
-914
-4% -$56K 0.64% 38
2023
Q2 		$1.35M Buy
21,119
+1,780
+9% +$119K 0.73% 34
2023
Q1 		$1.34M Buy
19,339
+1,560
+9% +$110K 0.74% 37
2022
Q4 		$1.28M Buy
17,779
+1,143
+7% +$86.2K 0.65% 35
2022
Q3 		$1.18M Sell
16,636
-357
-2% -$25.9K 0.61% 38
2022
Q2 		$1.31M Buy
16,993
+171
+1% +$13K 0.67% 41
2022
Q1 		$1.23M Sell
16,822
-269
-2% -$18.1K 0.54% 44
2021
Q4 		$1.07M Sell
17,091
-196
-1% -$11.5K 0.46% 49
2021
Q3 		$1.02M Buy
17,287
+1
+0% +$66 0.49% 48
2021
Q2 		$1.16M Sell
17,286
-106
-0.6% -$6.91K 0.56% 44
2021
Q1 		$1.1M Buy
17,392
+163
+0.9% +$10.1K 0.61% 40
2020
Q4 		$1.07M Sell
17,229
-1,384
-7% -$85.1K 0.74% 32
2020
Q3 		$1.12M Sell
18,613
-551
-3% -$33.2K 1% 29
2020
Q2 		$1.13M Buy
19,164
+45
+0.2% +$2.69K 1.08% 24
2020
Q1 		$1.07M Sell
19,119
-125
-0.6% -$7.64K 1.25% 20
2019
Q4 		$1.24M Hold
19,244
– – 1.04% 22
2019
Q3 		$976K Sell
19,244
-1,136
-6% -$53.4K 0.89% 24
2019
Q2 		$924K Sell
20,380
-3,283
-14% -$153K 0.87% 27
2019
Q1 		$1.13M Buy
+23,663
New +$1.18M 1.1% 18

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ategra Capital Management's BMY Position: Q2 2024 in Review

Ategra Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 12,342 shares — an estimated $669K sold.

Ategra Capital Management first reported a position in BMY in Q1 2019 and held it in 21 quarters. The position peaked at $1.35M in Q2 2023. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Ategra Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Ategra Capital Management sold 12,342 Bristol-Myers Squibb shares in Q2 2024, an estimated $669K.
  • Ategra Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 21 quarters.
  • Ategra Capital Management's Bristol-Myers Squibb position peaked at $1.35M in Q2 2023.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.